Form 8-K - Current report:
SEC Accession No. 0001070081-20-000137
Filing Date
2020-10-29
Accepted
2020-10-29 16:06:29
Documents
13
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ptct-20201029x8k.htm   iXBRL 8-K 44733
2 EX-99.1 ptct-20201029ex99135e319.htm EX-99.1 107444
  Complete submission text file 0001070081-20-000137.txt   285467

Data Files

Seq Description Document Type Size
3 EX-101.SCH ptct-20201029.xsd EX-101.SCH 3030
4 EX-101.LAB ptct-20201029_lab.xml EX-101.LAB 15412
5 EX-101.PRE ptct-20201029_pre.xml EX-101.PRE 9804
6 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20201029x8k_htm.xml XML 4728
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 201272662
SIC: 2834 Pharmaceutical Preparations